UroGen Pharma Ltd. (URGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for UroGen Pharma Ltd., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.34x | -3.60x | -4.23x | -1.84x | -1.92x | -3.05x |
| P/B Ratio | -10.68x | -51.87x | -6.63x | -2.26x | 25.26x | 4.07x |
| P/S Ratio | 10.26x | 5.05x | 5.23x | 3.14x | 4.42x | 33.26x |
| Profitability | ||||||
| Gross Margin | 88.7% | 90.2% | 88.7% | 88.1% | 89.3% | 91.4% |
| Operating Margin | -113.7% | -107.1% | -79.2% | -122.8% | -192.1% | -1074.2% |
| Net Margin | -139.8% | -140.4% | -123.6% | -170.6% | -230.7% | -1088.9% |
| EBITDA Margin | -123.6% | -105.5% | -73.0% | -118.4% | -190.4% | -1040.0% |
| Liquidity | ||||||
| Current Ratio | 4.01x | 6.01x | 5.42x | 5.39x | 5.11x | 5.39x |
| Quick Ratio | 3.65x | 5.81x | 5.24x | 5.21x | 4.90x | 5.30x |
| Leverage | ||||||
| Debt/Equity | -1.22x | -14.02x | -1.52x | -1.11x | 0.05x | 0.02x |
YoY = year-over-year change. Source: FMP..